Sensitivity Analyses of Clinical Trial Designs: Selecting Scenarios and Summarizing Operating Characteristics

08/08/2022
by   Larry Han, et al.
0

The use of simulation-based sensitivity analyses is fundamental to evaluate and compare candidate designs for future clinical trials. In this context, sensitivity analyses are especially useful to assess the dependence of important design operating characteristics (OCs) with respect to various unknown parameters (UPs). Typical examples of OCs include the likelihood of detecting treatment effects and the average study duration, which depend on UPs that are not known until after the onset of the clinical study, such as the distributions of the primary outcomes and patient profiles. Two crucial components of sensitivity analyses are (i) the choice of a set of plausible simulation scenarios {θ_1,...,θ_K} and (ii) the list of OCs of interest. We propose a new approach to choose the set of scenarios for inclusion in design sensitivity analyses. Our approach balances the need for simplicity and interpretability of OCs computed across several scenarios with the need to faithfully summarize – through simulations – how the OCs vary across all plausible values of the UPs. Our proposal also supports the selection of the number of simulation scenarios to be included in the final sensitivity analysis report. To achieve these goals, we minimize a loss function ℒ(θ_1,...,θ_K) that formalizes whether a specific set of K sensitivity scenarios {θ_1,...,θ_K} is adequate to summarize how the OCs of the trial design vary across all plausible values of the UPs. Then, we use optimization techniques to select the best set of simulation scenarios to exemplify the OCs of the trial design.

READ FULL TEXT

page 1

page 2

page 3

page 4

research
05/24/2021

Approximating the Operating Characteristics of Bayesian Uncertainty Directed Trial Designs

Bayesian response adaptive clinical trials are currently evaluating expe...
research
01/07/2022

New designs for Bayesian adaptive cluster-randomized trials

Adaptive approaches, allowing for more flexible trial design, have been ...
research
11/20/2017

Treatment Effect Quantification for Time-to-event Endpoints -- Estimands, Analysis Strategies, and beyond

A draft addendum to ICH E9 has been released for public consultation in ...
research
10/04/2018

ASIED: A Bayesian Adaptive Subgroup-Identification Enrichment Design

Developing targeted therapies based on patients' baseline characteristic...
research
01/24/2019

Seamless phase II/III clinical trials using early outcomes for treatment or subgroup selection: Methods and aspects of their implementation

Adaptive seamless designs combine confirmatory testing, a domain of phas...
research
08/11/2022

Adaptively Identifying Patient Populations With Treatment Benefit in Clinical Trials

We study the problem of adaptively identifying patient subpopulations th...
research
02/25/2020

The DURATIONS randomised trial design: estimation targets, analysis methods and operating characteristics

Background. Designing trials to reduce treatment duration is important i...

Please sign up or login with your details

Forgot password? Click here to reset